The microbiota contributes to the induction of both effector and regulatory responses in the gastrointestinal (GI) tract. However, the mechanisms controlling these distinct properties remain poorly understood. We previously showed that commensal DNA promotes intestinal immunity. Here, we find that the capacity of bacterial DNA to stimulate immune responses is species specific and correlated with the frequency of motifs known to exert immunosuppressive function. In particular, we show that the DNA of Lactobacillus species, including various probiotics, is enriched in suppressive motifs able to inhibit lamina propria dendritic cell activation. In addition, immunosuppressive oligonucleotides sustain T reg cell conversion during inflammation and limit pathogen-induced immunopathology and colitis. Altogether, our findings identify DNA-suppressive motifs as a molecular ligand expressed by commensals and support the idea that a balance between stimulatory and regulatory DNA motifs contributes to the induction of controlled immune responses in the GI tract and gut immune homeostasis. Further, our findings suggest that the endogenous regulatory capacity of DNA motifs enriched in some commensal bacteria could be exploited for therapeutic purposes. 
INTRODUCTION
The human intestine harbors 1,000 trillion microbes composed of an estimated 4,000 strains. 1 The commensal flora has a fundamental role in various aspects of host physiology, including tissue development, metabolism, and immunity. This symbiotic relationship is controlled, at least in part, by interaction of host cells with commensal-derived microbeassociated molecular patterns. Paradoxically, commensal and pathogenic microbes interact with the host immune system through similar conserved ligands such as the ones signaling through the Toll-like family of receptors (TLR). 2 TLR signaling in the intestinal epithelial compartment is critically involved in the maintenance of intestinal homeostasis and tissue repair. 3 Further, these signals also positively regulate the sampling of luminal contents by dendritic cells (DCs) from the underlying lamina propria (LP) compartment and can mediate tolerance to food antigens. 4, 5 TLR9 recognizes unmethylated cytosine phosphate guanosine (CpG) dinucleotides, which are abundant in prokaryotic DNA found in intestinal flora. In mice, we found that constitutive gut flora DNA sensing in the gastrointestinal (GI) tract can act as an immunological adjuvant and critically controls the balance between regulatory (T reg ) and effector T cells. 6 Although commensal communities can control immune system development and function, individual bacteria can have highly distinct properties. For instance, some bacteria, referred to as probiotics, can promote regulatory responses in the GI tract, while others, referred to as pathobionts, can, in some circumstances, contribute to pathology. 7, 8 Some of these distinct properties have been linked to the expression of defined ligands or expression of factors associated with enhanced adhesion with epithelial cells. However, the molecular basis of the functional disparities between commensal species remains poorly understood.
DNA from pathogenic bacteria are not all equal in their capacity to stimulate TLR9 and do so with various levels of efficiency that correlates with their frequency of CpG dinucleotides. 9, 10 Thus, it could be proposed that increased CpG motifs in the ARTICLES DNA of defined commensal bacteria may contribute to their enhanced inflammatory properties. An alternative possibility is that the DNA of a subset of commensal bacteria may be more enriched in what have been referred to as suppressive motifs. These motifs are poly guanosine-or [GC]-rich sequences, are enriched in the telomere region of mammalian DNA, and have been shown to selectively block immune activation induced by CpG oligonucleotides (ODN). 11 -14 Although their presence has not been reported in bacteria, we hypothesized that increased frequency of these motifs at the DNA level may potentially contribute to the functional specificity of commensal bacteria on host immune responses.
Our present results reveal that the capacity of bacterial DNA to stimulate immune responses is bacteria specific. Strikingly, suppressive motifs, enriched in the DNA of the probiotic of the Lactobacillus family, potently prevent DC activation and maintain T reg -cell conversion in the face of inflammation. Additionally, treatment of mice with suppressive ODN (sup-ODN) mitigates tissue damage and inflammation associated with oral Toxoplasma gondii infection and dextran sulfate sodium (DSS)-induced colitis. Altogether, our work provides evidence that DNA motifs in the microbiota may contribute to the hierarchy of commensal-derived signals and maintenance of gut immune homeostasis. Further, our findings suggest that the endogenous regulatory capacity of DNA motifs enriched in specific commensal bacteria could be harnessed for therapeutic purposes.
RESULTS

DNA from distinct commensal bacteria differentially stimulates intestinal immune responses
To assess whether functional differences in response to commensals is apparent at their DNA level, we evaluated the proinflammatory capacity of the DNA from two prototypic commensal bacteria with known divergent effects on the host immune system. In particular, we used DNA isolated from the probiotic Lactobacillus paracasei and a commensal with pathogenic potential Escherichia coli . 7 To ensure the predominance of these signals, we placed 3-week-old mice on a cocktail of antibiotics (ATBs). 3 After 6 weeks of the ATB course, mice were treated orally once a week with CpG ODN or highly purified genomic DNA from E. coli or L. paracasei . Two weeks later, mice were orally infected with the GI parasite Encephalitozoon cuniculi that induces strong T-helper (Th) type 17 and Th1 responses, the latter required for host protection. 6, 15 As previously shown, reduction of the gut flora significantly impaired both local and systemic interferon (IFN)-and interleukin (IL)-17 responses and compromised parasite control ( Figure 1a,b ) . 6 In a comparable manner to CpG ODN treatment, E. coli DNA significantly restored effector responses and parasite control ( Figure 1a,b ) . By contrast, DNA from L. paracasei failed to rescue either IFN-or IL-17 responses and consequently had no effect on the parasite burden compared with ATB treatment alone ( Figure 1a,b ) . Thus, at an equivalent dose, DNA from distinct bacterial species has a differential capacity to stimulate immune responses.
E. coli and L. paracasei DNA differentially activate LP DC (LpDC) and influence T reg -cell induction
The intestinal mucosa contains a large number of antigenpresenting cells that have an important role in shaping adaptive immunity in response to intestinal environmental cues. 16 We therefore assessed whether our in vivo observations could correlate with differential effects of L. paracasei and E. coli DNA on gut resident DCs by performing in vitro experiments using LpDC purified from naive mice. The small intestine LP contains both resident and migratory DCs, the latter tending to express high levels of CD103. 17, 18 Upon stimulation with CpG ODN, both LpDC subsets produced tumor necrosis factor (TNF)-and IL-12 / 23p40 ( Figure 2a ). High levels of IL-6 were also measured in the supernatant of CpG ODN-stimulated cultures of purified CD11c hi MHCII + (major histocompatibility complex) LpDCs ( Figure 2b ). Similarly, stimulation with E. coli DNA induced TNF-, IL-12 / 23p40, and IL-6 secretion by LpDCs albeit to a lower degree than highly purified CpG ODN ( Figure 2a,b ) . By contrast, a similar dose of L. paracasei DNA was not able to trigger proinflammatory cytokine production by LpDCs ( Figure 2a,b ) .
Another property of intestinal LpDCs is their ability to enhance transforming growth factor (TGF)--mediated T regcell conversion. 19 -22 We previously showed that gut flora DNA impaired T reg -cell conversion via its capacity to activate DCs. 6 We utilized this feature as a functional read out for the ex vivo effect of the DNA from E. coli and L. paracasei. Purified LpDCs and naive CD4 + Foxp3 − T cells were co-cultured in T reg -cellpolarizing conditions, in the presence or absence of CpG ODN or the two types of bacterial DNA. To specifically assess the effect of DNA on DCs, we utilized T cells from Tlr9 − / − mice. As we previously demonstrated, stimulation with CpG ODN led to a dramatic decrease in the frequency of Foxp3 + cells, whereas 4 7 expression, which mediates migration of cells to the gut, was maintained on Foxp3-negative cells ( Figure 2c ) . Similarly, the proportion of Foxp3 + cells was strongly reduced in a TLR9-dependent manner in the presence of E. coli -derived DNA ( Figure 2c and Supplementary Figure S1 online). By contrast, a similar amount of L. paracasei DNA had no effect on the induction of T reg cells ( Figure 2c ). To assess whether such an effect was due to a complete inability of the probiotic DNA to activate LpDC, we performed a similar assay in the presence of increasing doses of DNA. Using this approach, we found that L. paracasei DNA was not inert but 100 times less potent at inhibiting T reg -cell induction compared with the DNA of E. coli ( Figure 2d ). Thus, the L. paracasei DNA has the capacity to stimulate antigen-presenting cells but does so in a less efficient manner than the DNA from E. coli .
L. paracasei genome is enriched in immunosuppressive motifs
Previous studies have shown that, in vitro , DNA from distinct pathogenic bacteria stimulate TLR9 with varying levels of efficiency that correlate with the frequency of unmethylated CpG dinucleotides in their DNA. 9, 10 However, assessment of the frequency of prototypic stimulatory motifs AACGAT ARTICLES and ATCGAT in the sequenced genome of 27 strains of E. coli and 28 Lactobacillus species showed similar relative expression between E. coli and bacteria of the Lactobacillus genus (see Supplementary Tables 1 and 2 and Supplementary  Figure S2a online ). An alternative but not exclusive explanation for our aforementioned results is that DNA from L. paracasei would have increased regulatory capacity. We next compared the frequency of suppressive motifs. 23, 24 Notably, we found that the suppressive sequences, TTAGGG and TCAAGCTTGA, were enriched in the DNA of all Lactobacillus species compared with E. coli , including those with reported probiotic activities ( Figure S2b ,c online). These findings suggest that a shift in the ratio of regulatory vs. stimulatory motifs might contribute to the differential effect of commensal DNA on immune responses.
Sup-ODN reduce inflammatory cytokine production by gut antigen-presenting cells
Previous work has established that sup-ODN could inhibit the production of proinflammatory cytokines by CpG ODN-stimulated splenic cells. 13, 14, 25 To address the possibility that suppressive motifs could interfere with the adjuvant property of CpG ODN at mucosal sites, we synthesized two ODNs containing repeats of the suppressive sequences TTAGG or TCAAGCTTGA: A151 (sup-ODN1) and H154 (sup-ODN2), respectively. 23, 24 Addition of sup-ODN1 to the CpG ODNtreated cultures of DC purified from the small intestine LP significantly blocked their production of TNF-, IL-12 / 23p40, and IL-6 ( Figure 3c,d ) . Notably, co-treatment with control scrambled ODN (ns-ODN) that does not contain stimulatory or suppressive motifs had no effect on the secretion of TNF-, IL-12 / 23p40, and IL-6 by LpDCs following stimulation with CpG ODN ( Figure 3c,d ). Based on the profound inhibitory effect of sup-ODN on gut DC inflammatory cytokine production, we next assessed the physiological consequences of these motifs on gut immune responses and pathology.
Sup-ODN inhibit the adjuvant effect of CpG on intestinal immune responses
We first addressed the possibility that suppressive motifs could interfere with CpG adjuvant property at mucosal sites. A group of ATB-treated mice received CpG ODN alone or in combination with sup-ODN1 or sup-ODN2 starting a week before We and others previously showed that inflammation interferes with T reg -cell conversion in vitro and in vivo . 26, 27 To evaluate whether sup-ODN could prevent such an outcome, we first tested its potential effects in vitro . To this end, CpG ODN was added with or without sup-ODN1 to T reg -cell -polarizing co-cultures of LpDCs and naive CD4 + Foxp3 − T cells. After 5 days, the percentages of CD4 + cells expressing Foxp3 were measured by flow cytometry. As expected, the addition of CpG ODN strongly suppressed T reg -cell conversion ( Figure 5a,b ) . Strikingly, sup-ODN1 interfered with the inhibitory effect of CpG ODN, whereas ns-ODN, devoid of stimulatory or suppressive motifs, had no effect ( Figure 5a ,b ).
Treatment with sup-ODN sustains T reg -cell conversion and ameliorates the intestinal immunopathology during T. gondii infection and DSS-induced colitis
We next assessed the effect of sup-ODN on T reg -cell induction during an inflammatory response in vivo . To this end, we used the well-characterized model of acute infection with the intracellular protozoan parasite T. gondii . Following oral infection, 
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T. gondii induces a strong inflammatory response in the GI tract, and control of the parasite and development of immunopathology are under the control of IFN--producing CD4 + T cells and IL-22, respectively. 28, 29 Congenic CD4 + Foxp3 − T cells from OT-II Tg × Foxp3 eGFP mice were adoptively transferred into recipients that were infected, or not, with 10 cysts of the type II T. gondii strain ME-49. Recipient mice were then fed ovalbumin antigen dissolved in drinking water and treated every other day with sup-ODN1. As we have previously shown, the frequency of cells expressing Foxp3 de novo was dramatically reduced in the LP after infection ( Figure 6a ). 27 By contrast, infected recipient mice treated with sup-ODN1 sustained T reg -cell conversion to a greater extent compared with untreated infected animals ( Figure 6a ). Collectively, these data demonstrate that sup-ODNs are sufficient to maintain a cardinal feature of gut physiology, T reg -cell conversion, during acute infection.
Sup-ODNs have been shown to suppress inflammation in several experimental settings. 23,30 -32 Based on the role of sup-ODN in limiting LpDC activation and sustaining T reg -cell induction, we postulated that these suppressive motifs could represent a therapeutic approach to limit mucosal inflammation. C57BL / 6 mice were infected orally with T. gondii and treated orally or not with sup-ODN1. At day 9 post-infection, pathology and antigen-specific cytokine responses from various sites were evaluated. As previously observed, 33, 34 T. gondii oral infection induced the development of robust Th1 and proinflammatory cytokine responses (IFN-, TNF-, IL-6, and IL-22), in the small intestine LP, mesenteric lymph nodes and spleen ( Figure 6b ). As a byproduct of immune responses, mice developed a severe form of intestinal inflammation characterized by loss of epithelial architecture in the ileum, shortened villi, massive influx of inflammatory cells, and scattered patches of necrosis, as well as severe liver damage, indicated by increased concentrations of serum alanine aminotransferase ( Figure 6c,d ) . Strikingly, sup-ODN1 significantly reduced the Th1 response to T. gondii as well as the production of cytokines involved in T. gondii pathogenesis such as TNF-, IL-6 and IL-22, in all the compartments analyzed ( Figure 6b ). By contrast, the immunoregulatory cytokine IL-10 required to limit tissue damage in this model 35 was selectively increased in the LP of sup-ODN1 -treated animals compared 
with control mice ( Figure 6b ) . Notably, the reduced inflammatory response was also associated with reduced intestinal and liver pathology ( Figure 6c,d ). These effects were specific to the presence of suppressive motifs as control ns-ODN failed to downregulate inflammatory responses and pathology (see Supplementary Figure S3 online and data not shown). Further, the sup-ODN used in this experiment specifically limited inflammatory responses mediated by TLR9 signaling as treatment with sup-ODN1 in Tlr9 − / − mice had no effect (see Supplementary  Figure S4a ,b online). These findings show that treatment of mice with suppressive DNA motifs is sufficient to prevent the development of the catastrophic intestinal immunopathology observed during oral T. gondii infection.
To evaluate the suppressive role of sup-ODN in another model of mucosal inflammation, we used the well-established model of DSS-induced colitis. This model of colitis is associated with disruption of epithelial integrity that rapidly leads to acute gut inflammation and weight loss. 36 Strikingly, treatment with sup-ODN1, but not with ns-ODN, significantly limited weight loss associated with DSS administration ( Figure 6e ). Further, colon size was significantly maintained following sup-ODN treatment compared with control-treated animals ( Figure 6f ).
Altogether, these results demonstrate that sup-ODN can limit severe immunopathology in the GI tract.
DISCUSSION
Here we showed that the DNA of defined commensal bacteria can be enriched in suppressive motifs able to exert strong immunoregulatory effects on the mucosal immune system. These findings reveal suppressive DNA motifs as an additional microbiota-derived microbe-associated molecular pattern and support the idea that a balance between stimulatory and regulatory motifs at the commensal DNA level is likely to contribute to the maintenance of gut immune homeostasis and function. We propose a model in which the adjuvant properties of commensal DNA are tightly regulated by suppressive motifs allowing the induction of effector responses without triggering pathogenic responses.
The interaction between the host and the flora relies on a complex network of signals involving numerous bacterial species and microbial-derived ligands. This multitude of signals converges to establish a tonic, regulated but responsive mucosal environment. Indeed, maintenance of responsiveness against pathogenic microbes as well as protection against commensal translocation relies on the establishment of a dynamic equilibrium sustained, in part, by the stimulatory capacity of the flora. 37 Furthermore, recent work demonstrated that defined bacteria (e.g., segmented filamentous bacteria) or bacteria-derived products (e.g., bacterial polysaccharide A, DNA, ATP) could have a dominant role in promoting mucosal immune responses. 6,38 -40 
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In some instances, defined bacteria species have been associated with enhanced pathogenesis during mucosal inflammation and are over-represented in the gut of patients suffering from inflammatory bowel disease. 41 On the other hand, the microbiota can exert some strong immunoregulatory function via the induction and / or activation of T reg cells at mucosal sites. For instance, Bacteroides fragilis -derived polysaccharide A and indigenous bacteria from the genus Clostridium can expand or induce T reg cells. 42 -44 Recent data also demonstrate that a fraction of mucosal resident T reg are specific for commensal-derived antigens. 45 Further, some bacteria referred to as probiotics have been defined based on their beneficial effect to their host. 8 Promising results have been obtained with probiotics in the treatment of human inflammatory diseases of the intestine and in the prevention and treatment of atopic eczema in neonates and infants. 46, 47 The mechanisms behind these functional disparities between commensal species remain to date poorly understood, but has been associated, at least in part, with the induction of various T reg -cell populations. Previous work has identified an association between Crohn ' s disease and a promotor polymorphism in ARTICLES the Tlr9 gene in humans. 48 Such association supports the idea of a role for gut flora DNA sensing in the pathophysiology of inflammatory bowel diseases. We previously showed that the DNA of commensal bacteria can have a profound immunostimulatory role on mucosal immune responses. 6 Strikingly, when used in isolation the DNA of L. paracasei is significantly less efficient at inducing immune responses and activating DCs than the DNA of E. coli , a commensal known for its stimulatory capacity. However, we found that these differences in the immunostimulatory capacity of L. paracasei and E. coli DNA were not associated with differences in CpG motifs.
Krieg et al. 12 were the first to document the existence of suppressive or neutralizing DNA motifs in the genome of certain strains of adenovirus. Other inhibitory sequences were later characterized in mammalian DNA. In humans and mice, telomeric regions of chromosomes contain large numbers of singlestranded guanosine-rich hexanucleotide repeats of the motif TTAGGG. Synthetic ODNs composed of TTAGGG multimers have been developed and shown to have multiple effects on immune activation. 13, 14, 23 In particular, these sequences downregulate Th1 responses in the context of CpG ODN stimulation. 11, 12, 24, 25 Importantly, we find that the genomes of bacteria from the Lactobacillus genus, including the genome of various probiotic such as L. paracasei , are enriched in several suppressive motifs. We find that enrichment in suppressive motifs is a general feature of bacteria from the Lactobacillus genus, including bacteria with previously described probiotic activity. Although we cannot state that the relative enrichment of these suppressive motifs represents a unique feature to bacteria with known probiotic properties, we would like to mention that the regulatory functions of all members of the Lactobacillus genus have not been thoroughly studied at this time. These results support the idea that enrichment in suppressive DNA motifs is family specific. Our work reveals that these suppressive motifs have a potent immunoregulatory effect on the mucosal immune system. Indeed, these motifs potently inhibit CpG ODN -mediated LpDC activation and sustain mucosal T reg -cell conversion during inflammation both in vitro and in vivo . We also find that these motifs can limit immunopathology during acute intestinal infection. Complementing our results in an infectious model, we find that suppressive motifs potently inhibit the pathological consequences of DSS-induced colitis as well.
Despite their potent effect on immune responses, the exact mechanism of action of suppressive motifs remains poorly understood. Synthetic oligodeoxynucleotides composed of TTAGGG multimers can block the colocalization of CpG ODN with TLR9 in endosomal vesicles but not the binding or uptake of CpG ODN by immune cells. 11 Further, their immunosuppressive ability depends on their ability to make complex structures and to prevent STAT1, STAT3, and STAT4 phosphorylation. 25, 49 Consequently sup-ODN impair the production of various inflammatory mediators such as IL-12 production. 25 Interestingly, other nonimmunogenic nucleotides have been recently shown to strongly suppress CpG-induced innate responses by competing for high mobility group box proteins, known to be essential for triggering all nucleic acid receptormediated innate immune responses. 50 Understanding how these motifs inhibit DC activation and immunopathology in the context of TLR9 stimulation in the GI tract remains to be addressed.
Inflammatory bowel disease constitutes a significant health burden in developed countries impacting the quality of life of some 1.4 million individuals in North America and 2.2 million individuals in Europe. 51 There is now clear evidence that the microbiota is a major contributor to the initiation and amplification of mucosal inflammation. 41 Here, we propose that the potential pathogenic outcome associated with microbial dysbiosis may be, in part, associated with increased ratio of immunostimulatory vs. suppressive motifs at the DNA level, an event that could, in genetically predisposed individuals, tip the balance toward inflammation. 
Our findings add an additional layer in our understanding of the complex host -microbiota interaction and propose a model in which the proinflammatory capacity of bacterial DNA can be harnessed by its endogenous content in suppressive motifs. Further, our data support the idea that sup-ODN may represent an important therapeutic approach in the treatment of mucosal inflammatory responses.
METHODS
Mice . C57BL / 6 (WT) and B6 SJL mice were purchased from Taconic Farms. B6.129P2-Tlr9 tmAki ( Tlr9 − / − ) 52 mice were obtained from Dr S. Akira (Osaka University, Japan) via Dr R. Seder (Vaccine Research Center, NIH) and backcrossed 11 generations onto the C57BL / 6 background (Taconic, Germantown, NY). Foxp3 eGFP reporter mice (Foxp3 eGFP ) were obtained from Dr M. Oukka (Seattle Children ' s Research Institute). 26 Tlr9 − / − Foxp3 eGFP mice were generated by crossing the F1 progeny of Tlr9 − / − × Foxp3 eGFP breeders. We generated OT-II Tg × Foxp3 eGFP mice. All mice were bred and maintained under pathogen-free conditions at an American Association for the Accreditation of Laboratory Animal Care-accredited animal facility at the NIAID and housed in accordance with the procedures outlined in the Guide for the Care and Use of Laboratory Animals. All experiments were performed at the NIAID under an animal study proposal approved by the NIAID Animal Care and Use Committee. Mice between 6 and 12 weeks of age were used. Mice were sex-and age-matched for each experiment.
Parasite and infection protocol . A rabbit isolate of E. cuniculi obtained from Waterborne (New Orleans, LA) was used throughout the study. The parasites were maintained by continuous passage in rabbit kidney RK13 cells (ATCC CCL-37). Spores were collected from the culture medium, resuspended in sterile phosphate-buffered saline (PBS) pH 7.2, and immediately used for inoculation of mice or cell cultures. Mice were infected by intragastric gavage with 5 × 10 6 fresh spores. ME-49 clone C1 of T. gondii (kindly provided by Dr ME Grigg, NIAID / NIH) was obtained by electroporation of the parental ME-49 type II strain (ATCC 50840) with the red fluorescent protein and was used for production of tissue cysts in C57BL / 6 mice. Tissue cysts used in experiments were obtained from female mice that were perorally inoculated with 10 cysts 2 months earlier. Animals were killed and their brains removed and homogenized in 1 ml of PBS pH 7.2. Cysts were counted under an inverted fluorescent microscope on the basis of two aliquots of 20 l. For experiments, female mice were infected by intragastric gavage with 10 cysts of ME-49 C1.
Quantitation of parasite tissue loads . For experiments with E. cuniculi , duodenum was removed from infected mice and digested with proteinase K (Qiagen, Los Angeles, CA) after homogenization. DNA was subsequently extracted with the DNeasy Tissue kit from Qiagen. Quantitative real-time PCR was performed in triplicate with 50 ng of total tissue DNA, the iQ SYBR Green Supermix (BioRad, Richmond, CA), and the following primers specific for a 268-bp DNA sequence of the SSU rRNA gene from E. cuniculi : forward 5 Ј -GTGAGACCCTTTGACGGTGT-3 Ј and reverse 5 Ј -CTCAGACCTTCCGATCTTCG-3 Ј . Real-time PCR was conducted on a Bio-Rad iCycler under the following conditions: 3 min at 95 ° C; 40 cycles of 45 s at 95 ° C; 60 s at 60 ° C; and 45 s at 72 ° C. Genomic DNA was extracted from known amounts of E. cuniculi spores with the QIAamp DNA stool mini-kit (Qiagen) and used as PCR standards. A standard curve was generated by linear regression on plotted cycle threshold ( C T ) values of the standards against the logarithms of parasite numbers using iCycler iQ Optical System software (version 3.1; Bio-Rad).
Hs27 human fibroblast (ATCC CRL-1634) cultures were used for parasite burden quantitation following infection with T. gondii . Tissue single-cell suspensions (10 4 -10 6 cells) were added onto confluent fibroblast monolayers and titrated by looking at plaque formation under an inverted fluorescent microscope 6 to 8 days later. Results of these titrations are reported as plaque-forming units.
Genomic DNA extraction from bacteria . E. coli strain K12 substrain MG1655 was grown in tryptic soy broth medium (Fluka, St Louis, MO) under aerobic conditions at 37 ° C with constant shaking. L. paracasei strain ATCC 25302 was grown in Lactobacilli MRS broth (Hardy Diagnostic, Santa Maria, CA) under anaerobic conditions at 37 ° C. Overnight cultures of E. coli or L. paracasei were centrifuged at 3,300 g and 4 ° C for 20 min. Pellets were resuspended in lysis buffer (10 m M Tris / HCl, 50 m M ethylenediaminetetraacetic acid, pH 8.0) containing lysozyme (0.5 mg ml − 1 ; Sigma-Aldrich, St Louis, MO). After incubation at 37 ° C for 2 h, 2 mg ml − 1 of proteinase K and 1 % sodium dodecyl sulfate were added and the sample incubated at 60 ° C for 3 h. DNA was then purified by a series of seven consecutive phenol -chloroform -isoamyl alcohol affinity extractions. The quality and the amount of purified DNA were measured and quantified using a NanoDrop 3300 spectrophotometer (Thermo Scientific, Wilmington, DE Bioinformatics . Genome data were downloaded from NCBI Genomes database for 28 different species of Lactobacillus bacteria and 27 strains of E. coli (see Supplementary Tables 1 and 2 online) . The presence of the following sequence motifs in the genome of different bacteria was analyzed: AACGTT and ATCGAT for the CpG motifs and TTAGGG and TCAAGCTTGA for the suppressive motifs. 23, 24 " Perl " scripts were used to match the motif patterns to the bacteria sequences. Alternatively, the motifs were enumerated using the " fuzznuc " program of the EMBOSS package ( http://emboss.sourceforge.net ). Custom PHP scripts were written to extract and tabulate the results obtained using the above programs.
ATB treatment . Male, 3-week-old C57BL / 6 mice were provided ampicillin (1 g l − 1 ), neomycin trisulfate (1 g l − 1 ), metronidazole (1 g l − 1 ), and vancomycin (500 mg l − 1 ) in drinking water as previously described. 3 All ATBs were purchased from Sigma-Aldrich (St Louis, MO). Six weeks after the start of the ATB course, mice also received orally various treatments once a week: CpG ODN 1826 (100 g) in sterile PBS, DNA from E. coli (500 g), or DNA from L. paracasei (500 g) in sterile water. Two weeks later, mice were infected with E. cuniculi by gavage. In some experiments, mice were treated orally every 3 days with CpG ODN 1826 (25 g) alone or in combination with sup-ODN1 (25 g) starting 6 weeks after the beginning of the ATB regimen. Mice were then gavaged with E. cuniculi 6 days later.
In vitro restimulation and intracellular cytokine detection . RPMI 1640 supplemented with 10 % fetal bovine serum, 2 mM L-glutamine, 20 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethane sulfonic acid), 100 U ml − 1 penicillin, 100 g ml − 1 streptomycin, 100 g ml − 1 gentamicin, 50 mM of -mercaptoethanol, 1 mM sodium pyruvate and nonessential amino acids (complete medium) was used for in vitro restimulation. Single-cell suspensions of leukocytes from spleen, mesenteric lymph nodes and small intestinal LP of naive or infected mice were prepared as previously reported. 22 For experiment with E. cuniculi , 5 × 10 5 leukocytes were co-cultured with 1 × 10 5 bone marrow-derived DC in a 96-well U-bottom plate. Bone marrow-derived DC were previously incubated overnight with or without E. cuniculi spores (parasite:bone marrow-derived LpDC and T cell purification . LpDCs were purified from the small intestine of naive wild-type or Tlr9 − / − mice. After LP digests were passed through 70-and 40-m cell strainers, cells were resuspended in 1.077g cm − 3 iso-osmotic animal cell separation medium (Accurate Chemical & Scientific, Westbury, NY), and overlayed with RPMI 1640 medium. After centrifugation at 1,650 g for 15 min, cells were collected from the low-density fraction, washed, and then incubated with a mixture of antibodies containing -CD16 / 32 (2.4G2), -CD11c (HL-3), and -MHCII (AF6-120.1), as well as the non-DC components -TCR-(H57-597) and 7-AAD viability staining solution (all from eBioscience). DCs were defined as TCR-− CD11c hi MHCII + cells and sorted by flow cytometry on a FACSAria (BD Biosciences). The post-sort purity was higher than 95 % . Purified CD11c hi MHCII + cells were used for in vitro conversion assay or stimulated for 18 h with CpG ODN 1826, DNA from E. coli or L. paracasei , sup-ODN1, and / or non-sense ODN in the presence of granulocyte macrophage colony-stimulating factor (50 ng ml − 1 , Peprotech) in 5 % CO 2 . For T-cell purification, single-cell suspensions of spleen and peripheral lymph nodes extracted from Tlr9 − / − Foxp3 eGFP mice were enriched for CD4 + T cells by negative selection using an autoMACS Pro (Miltenyi Biotec). The enriched fraction was further labeled with fluorochrome-conjugated antibodies against CD4 (RM4-5), CD25 (7D4), and CD44 (IM7); all from eBioscience), and sorted by flow cytometry on a FACSAria. Purified CD4 + CD25 − CD44 lo Foxp3 − T cells ( < 0.5 % Foxp3 − ) were used for in vitro conversion assays.
In vitro conversion assay . Our conversion protocol was performed as previously reported 26 with T cells and LpDCs obtained as described above. In brief, FACS (fluorescence-activated cell sorter)-purified LpDCs and CD4 + T cells were co-cultured at a 1:10 ratio (1 × 10 5 CD4 + T cells) in complete medium and Treg cell -polarizing conditions: soluble -CD3
(1 g ml − 1 , BD Biosciences) and human recombinant TGF-(0.3 ng ml − 1 , R & D Systems). Co-cultures were supplemented with 5 ng ml − 1 of recombinant human IL-2 (Peprotech) every 2 days. In some experiments, CpG ODN 1555, sup-ODN1, ns-ODN, E. coli DNA, and L. paracasei DNA were added individually or in combination at various concentrations at the start of the co-cultures in Treg cell -polari zing conditions. On day 5, cells were stained with the LIVE / DEAD Fixable Blue Dead Cell Stain Kit and fluorochrome-conjugated antibodies against the cell-surface markers CD4 (RM4-5) and 4 7 (DATK32; all from eBioscience) in Hank ' s buffered salt solution for 20 min at 4 ° C and then washed twice. Foxp3 staining was subsequently performed using the Foxp3 staining set (eBioscience) according to the manufacturer ' s protocol.
Oral antigen administration . B6.SJL (CD45.1) mice were orally infected or not with 10 ME-49 C1 cysts of T. gondii . CD4 + Foxp3 − T lymphocytes from the secondary lymph nodes and spleen of naive OT-II Tg × Foxp3 eGFP (CD45.2) mice were purified by cell sorting and adoptively transferred into naive or infected (4 days post infection) B6.SJL recipient mice. Each mouse received 1.5 × 10 6 cells and was then fed with ovalbumin dissolved in drinking water (1.5 % solution; grade V from Sigma-Aldrich) for 5 consecutive days. On day 9 after infection, mesenteric lymph nodes and LP single-cell suspensions were prepared from B6.SJL hosts as described above and intracellular Foxp3 expression was assessed among CD45.1 + transferred cells. In some experiments, B6.SJL recipient mice were injected by gavage with 25 g of sup-ODN1 on days − 3 and − 1 before infection with T. gondii and on days 1, 3, 5, and 7 post-infection.
Pathology assessment . Mice treated or not with sup-ODN1 were euthanized 9 days post-oral infection with T. gondii . The ileum from each mouse was removed and immediately fixed in PBS containing 10 % formalin. Paraffin-embedded sections were cut at 0.5 mm, stained with hematoxylin and eosin and examined histologically. Liver alanine aminotransferase levels were measured in serum samples, using commercially available kits (Boerhinger Mannheim, Indianapolis, IN).
